Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ABCC3 is a novel target for the treatment of pancreatic cancer
Aleksandra Adamska, Riccardo Ferro, Rossano Lattanzio, et al.
Advances in Biological Regulation (2019) Vol. 73, pp. 100634-100634
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models
Ranjith Palanisamy, Nimnaka Indrajith Kahingalage, David Archibald, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2340-2340
Open Access | Times Cited: 8
Genetic and phenotypic profiling of single living circulating tumor cells from patients with microfluidics
Zaizai Dong, Yusen Wang, Gaolian Xu, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 19
Open Access | Times Cited: 8
Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
José J.G. Marı́n, María J. Monte, Rocı́o I.R. Macı́as, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3524-3524
Open Access | Times Cited: 28
Role of multidrug resistance-associated proteins in cancer therapeutics: past, present, and future perspectives
Ahmed Elfadadny, Hussein M. El‐Husseiny, Amira Abugomaa, et al.
Environmental Science and Pollution Research (2021) Vol. 28, Iss. 36, pp. 49447-49466
Closed Access | Times Cited: 37
MicroRNA-34 and gastrointestinal cancers: a player with big functions
Wei Gao, Jianping Zhou, Mohammadamin Morshedi
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
MiRNAs: main players of cancer drug resistance target ABC transporters
Forogh Mohammadi, Masoumeh Nejatollahi, Farhad Sheikhnia, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Bioactive lipids in cancer stem cells
Romana-Rea Begicevic, Frank Arfuso, Marco Falasca
World Journal of Stem Cells (2019) Vol. 11, Iss. 9, pp. 693-704
Open Access | Times Cited: 27
Pancreatic Adenocarcinoma: Unconventional Approaches for an Unconventional Disease
Christopher M. Gromisch, Motaz Qadan, Mariana Albuquerque Machado, et al.
Cancer Research (2020) Vol. 80, Iss. 16, pp. 3179-3192
Open Access | Times Cited: 24
Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma
Eduardo Ruiz-López, Ivana Jovčevska, Ruth González-Gómez, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 15
Comparative toxicity and liver transcriptomics of legacy and emerging brominated flame retardants following 5-day exposure in the rat
Keith R. Shockley, Michelle Cora, David E. Malarkey, et al.
Toxicology Letters (2020) Vol. 332, pp. 222-234
Open Access | Times Cited: 23
Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer
Aleksandra Adamska, Alice Domenichini, Emily Capone, et al.
Journal of Experimental & Clinical Cancer Research (2019) Vol. 38, Iss. 1
Open Access | Times Cited: 21
The implications of ABCC3 in cancer drug resistance: can we use it as a therapeutic target?
Adriana Ramírez-Cosmes, Edilburga Reyes-Jiménez, Cecilia Zertuche-Martínez, et al.
American Journal of Cancer Research (2021) Vol. 11, Iss. 9, pp. 4127-4140
Closed Access | Times Cited: 17
Inhibition of the Lysophosphatidylinositol Transporter ABCC1 Reduces Prostate Cancer Cell Growth and Sensitizes to Chemotherapy
Aikaterini Emmanouilidi, Ilaria Casari, Begum Gokcen Akkaya, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2022-2022
Open Access | Times Cited: 17
The Role of TRIP6, ABCC3 and CPS1 Expression in Resistance of Ovarian Cancer to Taxanes
Karolína Šeborová, Alžběta Spálenková, Kamila Koucká, et al.
International Journal of Molecular Sciences (2021) Vol. 23, Iss. 1, pp. 73-73
Open Access | Times Cited: 14
Interplay Between the Histone Variant H2A.Z and the Epigenome in Pancreatic Cancer
Pedro Antonio Ávila-López, Hober Nelson Núñez-Martínez, Carlos Alberto Peralta‐Álvarez, et al.
Archives of Medical Research (2022) Vol. 53, Iss. 8, pp. 840-858
Open Access | Times Cited: 7
Progress and challenges of multidrug resistance proteins in diseases.
Peilun Ding, Ying Gao, Junmin Wang, et al.
PubMed (2022) Vol. 12, Iss. 10, pp. 4483-4501
Closed Access | Times Cited: 6
ABCC3 and GSTM5 gene polymorphisms affect overall survival in Polish acute myeloid leukaemia patients
Aleksandra Butrym, Piotr Łacina, Katarzyna Bogunia‐Kubik, et al.
Current Problems in Cancer (2021) Vol. 45, Iss. 5, pp. 100729-100729
Closed Access | Times Cited: 8
Development of a Prognostic Five-Gene Signature for Diffuse Lower-Grade Glioma Patients
Qiang Zhang, Wenhao Liu, Shunbin Luo, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 6
Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells
Ji He, Piyush Bugde, Jiawei Li, et al.
Oncology Reports (2023) Vol. 51, Iss. 1
Open Access | Times Cited: 2
Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3
Kristi Y. Lee, Erica L. Beatson, Martina A. Knechel, et al.
Journal of Cancer (2023) Vol. 15, Iss. 3, pp. 615-622
Open Access | Times Cited: 2
Clinicopathological and Prognostic Significance of ABCC3 in Human Glioma
Dandong Fang, Wei Huang, Gang Cheng, et al.
Journal of Oncology (2021) Vol. 2021, pp. 1-8
Open Access | Times Cited: 5
Sensitizing cholangiocarcinoma to chemotherapy by inhibition of the drug-export pump MRP3
Maitane Asensio, Óscar Briz, Elisa Herráez, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117533-117533
Closed Access
Exploring Bile Acid Transporters As Key Players In Cancer Development And Treatment: Evidence From Preclinical And Clinical Studies
Bintee Bintee, Ruchira Banerjee, Mangala Hegde, et al.
Cancer Letters (2024), pp. 217324-217324
Closed Access
Identification of ABCC3 and its isoforms as potential biomarker in hepatocellular carcinoma
Cecilia Zertuche-Martínez, Juan Manuel Velázquez-Enríquez, Karina González-García, et al.
Toxicology Mechanisms and Methods (2023) Vol. 34, Iss. 4, pp. 398-407
Closed Access | Times Cited: 1
TRANSPORTERS AS THERAPEUTIC TARGETS IN HUMAN DISEASES
Robert S. Jones, Eugene C. Chen
(2022), pp. 497-514
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top